Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
31.98
+2.23
+(7.51%)
At close: 5:35:27 PM GMT+1
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
AFEYAN NOUBAR BOGHOS Director | Sale | Jul 31, 2024 | 6,856,160 |
BANCEL STEPHANE J Chief Executive Officer | Purchase | Mar 3, 2025 | -- |
BERENSON STEPHEN A. Director | Conversion of Exercise of derivative security | May 3, 2024 | 22,203 |
GARAY ARPA Officer | Sale | Dec 6, 2023 | 3,690 |
HOGE STEPHEN President | Conversion of Exercise of derivative security | Feb 28, 2025 | 1,606,780 |
HORNING SANDRA Director | Conversion of Exercise of derivative security | Apr 28, 2023 | 1,373 |
KLINGER SHANNON THYME Officer | Conversion of Exercise of derivative security | Feb 28, 2025 | 25,024 |
MOCK JAMES M Chief Financial Officer | Conversion of Exercise of derivative security | Feb 28, 2025 | 14,874 |
NABEL ELIZABETH G Director | Conversion of Exercise of derivative security | May 3, 2024 | 2,105 |
SAGAN PAUL L Director | Purchase | Mar 3, 2025 | -- |
Related Tickers
1BMRN.MI BIOMARIN PHARMACEUTICAL
65.64
+0.67%
TRDA Entrada Therapeutics, Inc.
10.55
-0.33%
IPSC Century Therapeutics, Inc.
0.6155
+1.30%
ERAS Erasca, Inc.
1.4050
-1.06%
NEXI NexImmune, Inc.
0.0001
-99.93%
LPTX Leap Therapeutics, Inc.
0.4400
+2.54%
LYRA Lyra Therapeutics, Inc.
0.1851
-0.70%
BPTH Bio-Path Holdings, Inc.
0.1625
-6.02%
AIM AIM ImmunoTech Inc.
0.1332
+1.29%
FDMT 4D Molecular Therapeutics, Inc.
4.1950
+0.84%